CoverageForm 410-K10-Q8-K13D13G13F

SXT · Sensient Technologies Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · SXT

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$1.61B$1.56B$1.46B$1.44B$1.38B$1.33B
Cost of Revenue$1.07B$1.05B$996.15M$908.25M--
Gross Profit$539.30M$507.09M$460.30M$528.78M--
R&D$52.90M$49.10M$48.10M$42.20M$34.30M$38.50M
SG&A$332.17M$315.51M$305.27M$292.36M$284.63M$271.09M
Total Operating Expenses------
D&A$61.10M$60.33M$57.82M$52.47M$52.05M$49.64M
Operating Income$207.13M$191.58M$155.02M$196.75M$170.03M$152.66M
Interest Expense$29.58M$28.78M$25.17M$14.55M$12.54M$14.81M
Income Tax$43.06M$38.13M$36.46M$41.32M$38.74M$28.37M
Net Income$134.49M$124.67M$93.39M$140.89M$118.75M$109.47M
EPS - Basic$3.18$2.96$2.22$3.36$2.82$2.59
EPS - Diluted$3.16$2.94$2.21$3.34$2.81$2.59

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$36.53M$26.63M$28.93M$20.92M$25.74M$24.77M
Accounts Receivable$305.38M$290.09M$272.16M$302.11M$261.12M$234.13M
Inventory$678.22M$600.30M$598.40M$564.11M$411.63M$381.35M
Accounts Payable$138.34M$139.05M$131.11M$142.37M$125.52M$107.32M
Current Assets$1.08B$961.89M$936.62M$934.78M$741.15M$741.59M
Total Assets$2.24B$2.02B$2.01B$1.98B$1.75B$1.74B
Current Liabilities$263.58M$270.64M$236.31M$272.15M$232.31M$215.96M
Long-term Debt$709.23M$613.52M$645.09M$630.33M$503.01M$518.00M
Total Liabilities------
Stockholders' Equity$1.19B$1.06B$1.05B$999.60M$938.42M$934.34M
Retained Earnings$1.85B$1.78B$1.73B$1.70B$1.63B$1.58B

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$127.83M$157.15M$169.70M$12.07M$145.22M$218.78M
Investing Cash Flow($92.68M)($59.21M)($87.62M)($98.45M)($35.56M)($33.42M)
Financing Cash Flow($35.03M)($81.55M)($82.00M)$86.18M($107.76M)($184.15M)
CapEx$89.41M$59.21M$87.87M$79.32M$60.79M$52.16M
Free Cash Flow$38.42M$97.94M$81.83M($67.25M)$84.43M$166.62M

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin33.5%32.6%31.6%36.8%--
Operating margin12.8%12.3%10.6%13.7%12.3%11.5%
EBITDA margin16.6%16.2%14.6%17.3%16.1%15.2%
Net margin8.3%8.0%6.4%9.8%8.6%8.2%
Free cash flow margin2.4%6.3%5.6%-4.7%6.1%12.5%
FCF / Net income0.290.790.88-0.480.711.52
R&D / Revenue3.3%3.2%3.3%2.9%2.5%2.9%
SG&A / Revenue20.6%20.3%21.0%20.3%20.6%20.4%
Effective tax rate24.3%23.4%28.1%22.7%24.6%20.6%
Return on assets6.0%6.2%4.6%7.1%6.8%6.3%
Return on equity11.3%11.8%8.9%14.1%12.7%11.7%
Return on invested capital8.2%8.8%6.6%9.3%8.9%8.3%
Liquidity
Current ratio4.103.553.963.433.193.43
Quick ratio1.531.341.431.361.421.67
Cash ratio0.140.100.120.080.110.11
Leverage
Debt / Equity0.590.580.610.630.540.55
Debt / Assets0.320.300.320.320.290.30
Debt / EBITDA2.642.443.032.532.262.56
Interest coverage7.0x6.7x6.2x13.5x13.6x10.3x
Equity multiplier1.881.911.911.981.861.86
Liabilities / Assets------
Efficiency
Asset turnover0.720.770.720.730.790.77
Inventory turnover1.581.751.661.61--
Days sales outstanding69d68d68d77d69d64d
Days inventory outstanding231d209d219d227d--
Days payable outstanding47d48d48d57d--
Cash conversion cycle253d228d239d246d--
Valuation
P / E29.7x24.2x29.9x21.8x35.6x28.5x
P / B3.4x2.8x2.6x3.1x4.5x3.3x
P / S2.5x1.9x1.9x2.1x3.1x2.3x
EV / EBITDA17.4x14.3x16.0x14.8x21.2x17.9x
Growth
Revenue growth (YoY)3.5%6.9%1.4%4.1%3.6%0.7%
Revenue CAGR (3y)3.9%4.1%3.0%2.8%-0.1%-2.1%
Revenue CAGR (5y)3.9%3.3%1.0%0.2%-1.5%-2.5%
Gross profit growth (YoY)6.4%10.2%-13.0%---
Operating income growth (YoY)8.1%23.6%-21.2%15.7%11.4%26.0%
Net income growth (YoY)7.9%33.5%-33.7%18.6%8.5%33.4%
EPS growth (YoY)7.5%33.0%-33.8%18.9%8.5%33.5%
EPS CAGR (3y)-1.8%1.5%-5.2%19.9%-8.8%8.5%
EPS CAGR (5y)4.1%8.7%-9.8%10.5%-0.1%2.3%
FCF growth (YoY)-60.8%19.7%---49.3%20.7%
FCF CAGR (5y)-25.4%-6.6%20.1%--9.8%28.2%
Book value growth (YoY)12.5%0.7%5.4%6.5%0.4%6.0%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

5/9
Neutral
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Industrial Organic Chemicals

CompanyRevenue (last FY)Net marginROE
LYB$30.15B-2.4%-7.3%
IFF$10.89B-3.3%-2.6%
WLK$11.17B-13.5%-17.2%
GEVO$160.58M-21.1%-7.3%
GPRE$2.09B-5.8%-15.8%

Comparing SENSIENT TECHNOLOGIES CORP against the 5 most active filers in the same SIC group.

Dividends

$1.64/share trailing 12 months · 0.0% YoY

Ex-datePer share
May 11, 2026$0.4100
Feb 3, 2026$0.4100
Nov 10, 2025$0.4100
Aug 4, 2025$0.4100
May 12, 2025$0.4100
Feb 4, 2025$0.4100
Nov 4, 2024$0.4100
Aug 5, 2024$0.4100
May 3, 2024$0.4100
Feb 5, 2024$0.4100
Nov 3, 2023$0.4100
Aug 4, 2023$0.4100
May 5, 2023$0.4100
Feb 6, 2023$0.4100
Nov 4, 2022$0.4100
Jul 29, 2022$0.4100
May 6, 2022$0.4100
Feb 1, 2022$0.4100
Oct 29, 2021$0.4100
Jul 30, 2021$0.3900
Apr 30, 2021$0.3900
Feb 1, 2021$0.3900
Oct 30, 2020$0.3900
Jul 31, 2020$0.3900